TrialsgrambetaRCTs are beautiful

CADeT-CS

2022

Deep Learning Computer-aided Polyp Detection Reduces Adenoma Miss Rate: A United States Multi-center Randomized Tandem Colonoscopy Study (CADeT-CS Trial)

In 232 patients undergoing screening or surveillance colonoscopy, CADe-assisted colonoscopy performed first reduced the adenoma miss rate at tandem colonoscopy compared with high-definition white-light colonoscopy performed first.

Result

Adenoma miss rate (AMR)
Absolute difference
11.13 points
NNT
9

Absolute difference and NNT are derived from the event rates.

Also reported: In 223 analysed patients; sessile serrated lesion miss rate 7.14% vs 42.11% (P=0.0482); first-pass adenomas per colonoscopy 1.19 vs 0.90 (P=0.0323). First-pass ADR 50.44% vs 43.64% (P=0.3091).

Original publication
Subtopic
Missed adenomas
Design
Multicentre single-blind randomised tandem-colonoscopy trial, USA
Relevance
Important: one of several pillars.
Source
Glissen Brown JR, et al. Clin Gastroenterol Hepatol. 2022;20(7):1499-1507.e4.doi 10.1016/j.cgh.2021.09.009

Discussion & critique

First US evidence for CADe and the first tandem design in the cluster, showing that the device finds adenomas human eyes pass over rather than merely more hyperplastic polyps. Small (232 randomised, 223 analysed), endoscopists unblinded by necessity, a miss-rate surrogate, and a non-significant first-pass ADR difference; the serrated-lesion result rests on 14 and 19 lesions.